Caio Cesar Souza Alves

Dr. Caio Cesar Souza Alves

Faculty of Medicine of Mucuri, Federal University of Jequitinhonha and Mucuri Valleys, Diamantina, Minas Gerais, Brazil
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2010 in International Immunology
Verified
Journal Article
Open access
PDF file
AMAna Márcia M. Mattos
Ana Márcia M. Mattos
CACaroline de S. Almeida
Caroline de S. Almeida
KFKees L. M. C. Franken
Kees L. M. C. Franken
Caio Cesar Souza AlvesCaio Cesar Souza Alves
Caio Cesar Souza Alves
CAClarice Abramo
Clarice Abramo
HTHenrique Couto Teixeira
Henrique Couto Teixeira
Detection of specific antibodies may represent an additional tool in diagnosis of tuberculosis (TB). Herein, levels of serum IgG antibodies against early secreted antigenic target (ESAT-6), culture filtrate antigen-10 (CFP-10) and 16kDa Mycobacterium tuberculosis antigens were measured in 33 active pulmonary TB patients (0M-TB), in 47 patients after 1–3 months of treatment (3M-TB) and in 22 patients who had completed 6 months of chemotherapy (6M-TB). The control group consisted of 38 BCG-vaccinated healthy controls (HC). In addition, IFN-γ, tumor necrosis factor (TNF)-α, IL-6, IL-2, IL-4 and IL-10 production in PBMC cultures from 20 patients were measured following stimulation with the M. tuberculosis-specific fusion protein ESAT-6/CFP-10. Elevated levels of IgG against ESAT-6, CFP-10 and 16kDa antigens were detected in 0M-TB and 3M-TB patients in comparison to the HC and 6M-TB groups. Receiver operating characteristic analysis indicated sensitivity of 85, 94 and 61% and specificity of 89, 87 and 89% for serum IgG against ESAT-6, CFP-10 and 16kDa, respectively. A predominant IgG1 response to ESAT-6 and CFP-10 was observed in 0M-TB patients, together with ESAT-6/CFP-10-specific IFN-γ, TNF-α and IL-6 that were produced at lower levels in the 6M-TB group. These data indicate that a Th1 phenotype against early phase Mtb antigens appears to be dominant in the peripheral blood of patients with active pulmonary TB that is reduced after chemotherapy. Taken together, ESAT-6/CFP-10 cytokine tests together with detecting IgG antibodies specific to ESAT-6 and CFP-10 may be the useful TB disease biomarkers in monitoring treatment success.

31 March 2017 in Clinical and Experimental Immunology
Verified
Journal Article
Closed access
PDF file
FSF M C Silva
F M C Silva
EOE E Oliveira
E E Oliveira
Caio Cesar Souza AlvesCaio Cesar Souza Alves
Caio Cesar Souza Alves
ABA S S Brugiolo
A S S Brugiolo
CAC C Alves
C C Alves
AFA P Ferreira
A P Ferreira

27 January 2009 in Plant Breeding
Verified
Journal Article
Closed access
PDF file
JCJ. M. S. Campos
J. M. S. Campos
LDL. C. Davide
L. C. Davide
CSC. C. Salgado
C. C. Salgado
FSF. C. Santos
F. C. Santos
PCP. N. Costa
P. N. Costa
APA. V. Pereira
A. V. Pereira

1 August 2017 in Pulmonary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
ABAlessa Sin Singer Brugiolo
Alessa Sin Singer Brugiolo
AGAna Cláudia Carvalho Gouveia
Ana Cláudia Carvalho Gouveia
Caio Cesar Souza AlvesCaio Cesar Souza Alves
Caio Cesar Souza Alves
FSFlávia Márcia de Castro e Silva
Flávia Márcia de Castro e Silva
ÉOÉrick Esteves de Oliveira
Érick Esteves de Oliveira
AFAna Paula Ferreira
Ana Paula Ferreira

1 February 2012 in International Immunopharmacology
Verified
Journal Article
Closed access
SCSandra Castro
Sandra Castro
celso de oliveira Rezende Júniorcelso de oliveira Rezende Júnior
celso de oliveira Rezende Júnior
Caio Cesar Souza AlvesCaio Cesar Souza Alves
Caio Cesar Souza Alves
ADAlyria T. Dias
Alyria T. Dias
LALívia L. Alves
Lívia L. Alves
AFAna Paula Ferreira
Ana Paula Ferreira

4 August 2009 in Immunology
Verified
Journal Article
Open access
PDF file
MRMichele F. Rodrigues
Michele F. Rodrigues
MBMichele M. Barsante
Michele M. Barsante
Caio Cesar Souza AlvesCaio Cesar Souza Alves
Caio Cesar Souza Alves
MSMaria A. Souza
Maria A. Souza
AFAna P. Ferreira
Ana P. Ferreira
HTHenrique Couto Teixeira
Henrique Couto Teixeira
Summary: Apoptosis of macrophages infected with pathogenic mycobacteria is an alternative host defence capable of removing the environment supporting bacterial growth. In this work the influence of virulence and bacterial load on apoptosis of alveolar macrophages during the initial phase of infection by Mycobacterium bovis was investigated. BALB/c mice were infected intratracheally with high or low doses of the virulent (ATCC19274) or attenuated (bacillus Calmette–Guérin Moreau) strains of M. bovis. The frequency of macrophage apoptosis, the growth of mycobacteria in macrophages, and the in situ levels of the cytokines tumour necrosis factor‐α (TNF‐α), interleukin‐10 (IL‐10) and IL‐12 and of the anti‐apoptotic protein Bcl‐2 were measured at day 3 and day 7 post‐infection. An increase of macrophage apoptosis was observed after infection with both strains but the virulent strain induced less apoptosis than the attenuated strain. On the 3rd day after infection with the virulent strain macrophage apoptosis was reduced in the high‐dose group, while on the 7th day post‐infection macrophage apoptosis was reduced in the low‐dose group. Inhibition of apoptosis was correlated with increased production of IL‐10, reduced production of TNF‐α and increased production of Bcl‐2. In addition, the production of IL‐12 was reduced at points where the lowest levels of macrophage apoptosis were observed. Our results indicate that virulent mycobacteria are able to modulate macrophage apoptosis to an extent dependent on the intracellular bacterial burden, which benefits its intracellular growth and dissemination to adjacent cells.